Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Erasca
Biotech
Erasca lays off 18%, swaps out KRAS program for fresh options
Erasca is spending $22.5 million to import fresh KRAS and molecular glue assets while clearing space in its pipeline and laying off 18% of staff.
James Waldron
May 17, 2024 5:30am
Erasca erases part of pipeline after revealing mixed cancer data
Jun 6, 2023 10:00am
Erasca slides a Novartis melanoma med into pipeline for $20M
Dec 9, 2022 10:50am
Erasca nabs $300M IPO to attack cancer's favorite pathway
Jul 16, 2021 10:10am
